- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Peripheral T-cell Lymphoma in United Kingdom
Total 4543 results
-
Weiyun AiCelgene CorporationCompletedLymphoma | T-Cell Lymphoma | Cutaneous LymphomaUnited States
-
Pierluigi PorcuMillennium Pharmaceuticals, Inc.; Celgene CorporationCompletedPeripheral T-cell Lymphoma | Anaplastic Large Cell Lymphoma | Angioimmunoblastic T-cell Lymphoma | Adult Nasal Type Extranodal NK/T-cell Lymphoma | Hepatosplenic T-cell Lymphoma | Post-transplant Lymphoproliferative Disorder | Recurrent Adult T-cell Leukemia/Lymphoma | Recurrent Cutaneous T-cell... and other conditionsUnited States
-
Northwestern UniversityRecruitingCutaneous T Cell LymphomaUnited States
-
Fox Chase Cancer CenterCelgene Corporation; Seagen Inc.Active, not recruitingCutaneous T-cell Lymphoma (CTCL)United States
-
Abramson Cancer Center of the University of PennsylvaniaCompletedCutaneous T Cell LymphomaUnited States
-
Northwestern UniversityNot yet recruitingCutaneous T Cell LymphomaUnited States
-
NYU Langone HealthLudwig Institute for Cancer ResearchTerminatedCutaneous T-cell LymphomaUnited States
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)Active, not recruitingRecurrent Angioimmunoblastic T-Cell Lymphoma | Recurrent Mycosis Fungoides | Recurrent Primary Cutaneous T-Cell Non-Hodgkin Lymphoma | Refractory Angioimmunoblastic T-Cell Lymphoma | Refractory Mature T-Cell and NK-Cell Non-Hodgkin Lymphoma | Refractory Mycosis Fungoides | Refractory Anaplastic... and other conditionsUnited States
-
Acrotech Biopharma Inc.CompletedPeripheral T-cell LymphomaUnited States
-
Cyclacel Pharmaceuticals, Inc.TerminatedA Randomized Phase II Study of Oral Sapacitabine in Patients With Advanced Cutaneous T-cell LymphomaCutaneous T-cell Lymphoma (CTCL)United States
-
Affimed GmbHCompletedPeripheral T Cell Lymphoma | Transformed Mycosis FungoidesSpain, United States, Korea, Republic of, Italy, France, Australia, Germany, Poland, Turkey, Russian Federation
-
Stanford UniversityTerminatedMycosis Fungoides | Lymphomas: Non-Hodgkin | Lymphomas: Non-Hodgkin Peripheral T-Cell | Lymphomas: Non-Hodgkin Cutaneous LymphomaUnited States
-
University of Michigan Rogel Cancer CenterCompletedLymphoma, T-CellUnited States
-
Yale UniversitySidney Kimmel Comprehensive Cancer Center at Johns Hopkins; Massey Cancer CenterWithdrawnLymphoma | Relapsed and Refractory Aggressive B- and T-cell LymphomasUnited States
-
University of WashingtonNational Cancer Institute (NCI)TerminatedCutaneous T-cell Lymphoma Stage I | Cutaneous T-cell Lymphoma Stage II | Cutaneous T-cell Lymphoma Stage III | Cutaneous T-cell Lymphoma Stage IVUnited States
-
Memorial Sloan Kettering Cancer CenterRecruitingCutaneous T-cell LymphomaUnited States
-
EQRx International, Inc.No longer availableExtranodal NK/T-cell LymphomaUnited States
-
Adam LernerNovartisTerminated
-
M.D. Anderson Cancer CenterGalderma R&DCompleted
-
TetraLogic PharmaceuticalsUnknownCutaneous T-Cell Lymphoma (CTCL)United States
-
M.D. Anderson Cancer CenterActive, not recruitingRefractory B-Cell Non-Hodgkin Lymphoma | Recurrent B-Cell Non-Hodgkin Lymphoma | Recurrent Mycosis Fungoides | Refractory Mycosis Fungoides | Recurrent Classic Hodgkin Lymphoma | Refractory Classic Hodgkin Lymphoma | Refractory Anaplastic Large Cell Lymphoma | Recurrent Anaplastic Large Cell Lymphoma and other conditionsUnited States
-
TetraLogic PharmaceuticalsPPD; The Leukemia and Lymphoma Society; Veristat, Inc.; Therapeutics, Inc.CompletedLymphoma, T-Cell, CutaneousUnited States
-
Therapeutic Advances in Childhood Leukemia ConsortiumPfizerCompletedLymphoblastic Lymphoma | Peripheral T-cell Lymphoma | Lymphoblastic Leukemia, Acute, ChildhoodUnited States, Canada, Australia
-
National Cancer Institute (NCI)RecruitingChronic Lymphocytic Leukemia (CLL) | Hairy Cell Leukemia (HCL) | Cutaneous T Cell Lymphoma (CTCL) | Non-Hodgkins Lymphoma (NHL) | Adult T Cell Lymphoma (ATL)United States
-
SethiMerck Sharp & Dohme LLCRecruitingT-Cell LymphomaUnited States
-
Ryan WilcoxUniversity of Michigan Rogel Cancer Center; TakedaActive, not recruitingLymphoma, T-Cell, PeripheralUnited States
-
Haihe Biopharma Co., Ltd.RecruitingAdvanced Solid Tumor | Epithelioid Sarcoma | Peripheral T Cell Lymphoma | FL LymphomaChina, United States
-
Jiangsu Simcere Pharmaceutical Co., Ltd.RecruitingAdvanced Solid Tumor | Cutaneous T-cell Lymphoma (CTCL)United States
-
Washington University School of MedicineSecuraBioRecruitingT-Cell LymphomaUnited States
-
Yale UniversityCompletedT Cell LymphomaUnited States
-
City of Hope Medical CenterNational Cancer Institute (NCI)RecruitingSezary Syndrome | Recurrent Mycosis Fungoides | Refractory Mycosis Fungoides | Recurrent Mature T- and NK-Cell Non-Hodgkin Lymphoma | Folliculotropic Mycosis Fungoides | Refractory Peripheral T-Cell Lymphoma, Not Otherwise Specified | Recurrent Cutaneous T-Cell Non-Hodgkin Lymphoma | Refractory Cutaneous...United States
-
University of Kansas Medical CenterSeagen Inc.Recruiting
-
Eisai Inc.National Cancer Institute (NCI); Tufts Medical Center; Ligand PharmaceuticalsCompleted
-
Wake Forest University Health SciencesNational Cancer Institute (NCI)RecruitingNon Hodgkin Lymphoma | Relapsed T-Cell Lymphoma | Refractory T-Cell LymphomaUnited States
-
Boston UniversityLigand PharmaceuticalsCompletedCutaneous T-Cell LymphomaUnited States
-
National Cancer Institute (NCI)CompletedAnaplastic Large Cell Lymphoma | Recurrent Adult Non-Hodgkin Lymphoma | Angioimmunoblastic T-Cell Lymphoma | Hepatosplenic T-Cell Lymphoma | Mature T-Cell and NK-Cell Non-Hodgkin Lymphoma | Recurrent Adult T-Cell Leukemia/Lymphoma | Adult Nasal Type Extranodal NK/T-Cell LymphomaUnited States, Canada
-
University of NebraskaNational Cancer Institute (NCI)CompletedAnaplastic Large Cell Lymphoma, ALK-Positive | Hepatosplenic T-Cell Lymphoma | Peripheral T-Cell Lymphoma, Not Otherwise Specified | Anaplastic Large Cell Lymphoma, ALK-Negative | Stage II Angioimmunoblastic T-cell Lymphoma | Stage II Enteropathy-Associated T-Cell Lymphoma | Stage III Angioimmunoblastic... and other conditionsUnited States
-
Galderma R&DCompletedCutaneous T Cell LymphomaUnited States, France, Germany
-
Dana-Farber Cancer InstituteMassachusetts General Hospital; Beth Israel Deaconess Medical CenterTerminated
-
miRagen Therapeutics, Inc.CompletedChronic Lymphocytic Leukemia (CLL) | Cutaneous T-cell Lymphoma (CTCL) | Mycosis Fungoides (MF) | Diffuse Large B-Cell Lymphoma (DLBCL), ABC Subtype | Adult T-Cell Leukemia/Lymphoma (ATLL)United States
-
Bio-Path Holdings, Inc.RecruitingFollicular Lymphoma | Hodgkin Lymphoma | Waldenstrom Macroglobulinemia | Mantle Cell Lymphoma | Marginal Zone Lymphoma | Chronic Lymphocytic Leukemia (CLL) | Small Lymphocytic Lymphoma (SLL) | DLBCL | Cutaneous T-cell Lymphoma (CTCL) | Peripheral T-cell Lymphoma (PTCL)United States
-
Bausch Health Americas, Inc.CompletedRefractory Cutaneous T-cell LymphomaUnited States
-
Acrotech Biopharma Inc.CompletedCutaneous T-cell LymphomaUnited States
-
Oncotartis, Inc.UnknownLymphoma | Lymphoma, Follicular | Lymphoma, B-Cell | Lymphoma, Non-Hodgkin | Lymphoma, T-Cell | Lymphoma, Hodgkin | Lymphoma, Peripheral T-CellUnited States
-
Mayo ClinicNational Cancer Institute (NCI)Completed
-
Eli Lilly and CompanyCompletedCutaneous T-Cell LymphomaUnited States
-
miRagen Therapeutics, Inc.TerminatedCutaneous T-Cell Lymphoma/Mycosis FungoidesUnited States, France, Spain, Canada, United Kingdom, Australia, Italy, Belgium
-
M.D. Anderson Cancer CenterCompletedLymphoma | Disorder Related to Bone Marrow TransplantationUnited States
-
Dartmouth-Hitchcock Medical CenterActive, not recruitingCutaneous T Cell Lymphoma | Graft Versus Host DiseaseUnited States
-
Eisai Inc.CompletedLymphoma, T-Cell, PeripheralUnited States